NEUROCRINE BIOSCIENCES WILL HOST CONFERENCE CALL AND WEBCAST TO PRESENT
THIRD QUARTER 2003 FINANCIAL RESULTS
THIRD QUARTER 2003 FINANCIAL RESULTS
COMPANY WILL ALSO PROVIDE UPDATE ON CLINICAL DEVELOPMENT PROGRAMS
SAN DIEGO, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report third quarter 2003 financial results after the Nasdaq market closes on Monday, November 3, 2003. Neurocrine will also host a live conference call and webcast Tuesday morning, November 4, 2003 at 8:30 AM EST / 5:30 AM PST. Participants may access the live conference call by dialing 1-800-227-9428 (US); 785-832-1508 (International) and using the Conference ID: NBIX. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com or alternatively through a link provided by PRNewswire at: http://www.firstcallevents.com/service/ajwz392355528gf12.html .
Gary A. Lyons, President and CEO of Neurocrine Biosciences and Paul W. Hawran, Executive Vice President and CFO of Neurocrine Biosciences will present the third quarter 2003 financial results and will provide an update on the Company's multiple clinical development programs. If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Jones or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600. A replay of the conference call will be available approximately two hours after the call by dialing 1-800-934-3335 (US); 402-220-1145 (International) and will be archived until Tuesday, November 18, 2003.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, autoimmunity and certain female and male health disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com .
SOURCE Neurocrine Biosciences, Inc.